<div id="readability-page-1"><div> By Katherine Hamilton <pre></pre> Senseonics shares slid after the company announced the pricing of its planned underwritten public offering. Shares fell 24% to $5.04 on Friday, at one point touching a 52-week low of $4.96. The stock has lost 9% of its value this year. The maker of implantable glucose trackers said late Thursday night it would price its underwritten public offering of 8 million shares at $5 apiece. It is also offering 8 million pre-funded warrants for just under $5 apiece. Senseonics expects proceeds to be $80 million. It has granted underwriters a 30-day option to buy up to an additional 2.4 million shares at the public offering price, less underwriting discounts and commissions. The offering is set to close May 4. <pre></pre> Write to Katherine Hamilton at katherine.hamilton@wsj.com <pre></pre> (END) Dow Jones Newswires May 01, 2026 14:37 ET (18:37 GMT)Copyright (c) 2026 Dow Jones &amp; Company, Inc.</div></div>

Senseonics控股

纳斯达克生物科技指数 ETF - iShares Nasdaq

标普生物技术 ETF - SPDR

医药突破 ETF - ALPS

标普生物技术 3 倍做多 - Direxion

生物科技 ETF - VanEck Vectors

纽交所高增长板生物技术指数 ETF - First Trust

动态生物技术与基因组 ETF - Invesco

Senseonics 的股价在宣布以每股 5 美元的价格进行承销公开发行后下跌了 24%，至 5.04 美元。该公司计划发行 800 万股股票和 800 万份预先融资的认股权证，预计筹集 8000 万美元。今年以来，该股已损失 9% 的价值，创下 52 周低点 4.96 美元。此次发行预计将于 5 月 4 日结束，承销商获得了 30 天的选择权，可以额外购买 240 万股

Senseonic Shares Slide on Underwritten Offering Price

MorningStar

Senseonic 的股票因包销发行价格下跌